465 related articles for article (PubMed ID: 1085288)
21. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
Cerny J; Stiller RA
J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
[TBL] [Abstract][Full Text] [Related]
22. Replication of murine leukemia virus in bone marrow-derived lymphocytes.
Ruddle NH; Armstrong MK; Richards FF
Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3714-8. PubMed ID: 185625
[TBL] [Abstract][Full Text] [Related]
23. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
24. Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus.
Hankins WD; Krantz SB
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5287-91. PubMed ID: 6933561
[TBL] [Abstract][Full Text] [Related]
25. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
26. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
Brightman BK; Li QX; Trepp DJ; Fan H
J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
[TBL] [Abstract][Full Text] [Related]
27. B and T lymphocyte activation by murine leukemia virus infection.
Bendinelli M; Friedman H
Adv Exp Med Biol; 1979; 121B():91-7. PubMed ID: 317564
[TBL] [Abstract][Full Text] [Related]
28. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes.
Isaak DD; Price JA; Reinisch CL; Cerny J
J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476
[No Abstract] [Full Text] [Related]
29. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
30. Suppression of natural killer cell activity by Friend murine leukemia virus.
Moody DJ; Specter S; Bendinelli M; Friedman H
J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
[TBL] [Abstract][Full Text] [Related]
31. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
Schultz KR; Klarnet JP; Gieni RS; HayGlass KT; Greenberg PD
Science; 1990 Aug; 249(4971):921-3. PubMed ID: 2118273
[TBL] [Abstract][Full Text] [Related]
32. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
Coppola MA; Green WR; Rich RF
Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
[TBL] [Abstract][Full Text] [Related]
33. Effect of T- and B-lymphocyte mitogens on interactions between lymphocytes and macrophages.
Stoecker CA; Rickard BM; Abel CA
Cell Immunol; 1978 Feb; 35(2):362-77. PubMed ID: 304382
[No Abstract] [Full Text] [Related]
34. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
Cloyd MW; Evans LH
J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
[TBL] [Abstract][Full Text] [Related]
35. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes.
Miyazawa M; Nishio J; Chesebro B
J Exp Med; 1988 Nov; 168(5):1587-605. PubMed ID: 3141552
[TBL] [Abstract][Full Text] [Related]
36. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
37. The effect of glutamine on murine splenic leukocyte responses to T and B cell mitogens.
Griffiths M; Keast D
Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():405-8. PubMed ID: 2097296
[TBL] [Abstract][Full Text] [Related]
38. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice.
Greenberger JS; Shadduck RK; Jaenisch R; Waheed A; Sakakeeny MA
Cancer Res; 1981 Sep; 41(9 Pt 1):3556-65. PubMed ID: 6266658
[TBL] [Abstract][Full Text] [Related]
39. Dextran-triggered T cells heighten T- and B-cell reactions to mitogens.
Alevy YG; Battisto JR
Immunology; 1976 Mar; 30(3):379-90. PubMed ID: 1082852
[TBL] [Abstract][Full Text] [Related]
40. Role of interleukin 2 on enhancement of concanavalin A-induced human peripheral blood lymphocyte proliferation by murine B cell mitogens.
Nitta T; Konno-Ejiri H; Okumura S; Ozawa A; Nakano M
Microbiol Immunol; 1985; 29(5):441-9. PubMed ID: 3875780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]